Donald A. Bergstrom
CIK: 0001709772
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Relay Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (24 total)
- Oct 28, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct2.3K shares at avg. $18.62$42K - Sep 8, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct8.5K shares at avg. $18.97$162K - Jul 28, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct2.2K shares at avg. $18.61$42K - Jul 6, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct8.7K shares at avg. $18.71$162K - Jun 22, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct93.5K shares at avg. $16.94$1.6M - Jun 22, 2026RLAY
Relay Therapeutics, Inc.
Exercise(M)Direct93.5K shares at avg. $4.12$385K - Apr 28, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct1.5K shares at avg. $14.79$22K - Jan 28, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct2.7K shares at avg. $8.45$23K - Jan 27, 2026RLAY
Relay Therapeutics, Inc.
Sale(S)Direct18.9K shares at avg. $7.62$144K - Jan 13, 2026RLAY
Relay Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
575K shares- - Oct 28, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct30.9K shares at avg. $7.29$225K - Jul 29, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct26.7K shares at avg. $3.68$98K - Jul 28, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct4.1K shares at avg. $3.74$15K - Apr 30, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct27.5K shares at avg. $3.00$82K - Apr 28, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct4.1K shares at avg. $3.17$13K - Mar 27, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct986 shares at avg. $2.84$3K - Jan 30, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct30.8K shares at avg. $4.42$136K - Jan 29, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct46.4K shares at avg. $4.55$211K - Jan 28, 2025RLAY
Relay Therapeutics, Inc.
Award(A)Direct176.4K shares- - Jan 28, 2025RLAY
Relay Therapeutics, Inc.
Sale(S)Direct3.2K shares at avg. $4.63$15K - Jan 10, 2025RLAY
Relay Therapeutics, Inc.
Award(A)DirectStock Option (Right to Buy)
400K shares- - Dec 27, 2024RLAY
Relay Therapeutics, Inc.
Sale(S)Direct657 shares at avg. $4.38$3K - Oct 28, 2024RLAY
Relay Therapeutics, Inc.
Sale(S)Direct2.7K shares at avg. $6.06$16K - Sep 27, 2024RLAY
Relay Therapeutics, Inc.
Sale(S)Direct648 shares at avg. $7.51$5K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 28, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 2,252 | $18.62 | $41,932 | Direct |
| Sep 8, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 8,530 | $18.97 | $161,814 | Direct |
| Jul 28, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 2,237 | $18.61 | $41,631 | Direct |
| Jul 6, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 8,660 | $18.71 | $162,029 | Direct |
| Jun 22, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 93,456 | $16.94 | $1,583,145 | Direct |
| Jun 22, 2026 | RLAY Relay Therapeutics, Inc. | Exercise(M) | 93,456 | $4.12 | $385,039 | Direct |
| Apr 28, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 1,490 | $14.79 | $22,037 | Direct |
| Jan 28, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 2,686 | $8.45 | $22,697 | Direct |
| Jan 27, 2026 | RLAY Relay Therapeutics, Inc. | Sale(S) | 18,895 | $7.62 | $143,980 | Direct |
| Jan 13, 2026 | RLAY Relay Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 575,000 | - | - | Direct |
| Oct 28, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 30,897 | $7.29 | $225,239 | Direct |
| Jul 29, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 26,701 | $3.68 | $98,260 | Direct |
| Jul 28, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 4,069 | $3.74 | $15,218 | Direct |
| Apr 30, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 27,472 | $3.00 | $82,416 | Direct |
| Apr 28, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 4,090 | $3.17 | $12,965 | Direct |
| Mar 27, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 986 | $2.84 | $2,800 | Direct |
| Jan 30, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 30,823 | $4.42 | $136,238 | Direct |
| Jan 29, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 46,407 | $4.55 | $211,152 | Direct |
| Jan 28, 2025 | RLAY Relay Therapeutics, Inc. | Award(A) | 176,400 | - | $0 | Direct |
| Jan 28, 2025 | RLAY Relay Therapeutics, Inc. | Sale(S) | 3,220 | $4.63 | $14,909 | Direct |
| Jan 10, 2025 | RLAY Relay Therapeutics, Inc. | Award(A) Stock Option (Right to Buy) | 400,000 | - | - | Direct |
| Dec 27, 2024 | RLAY Relay Therapeutics, Inc. | Sale(S) | 657 | $4.38 | $2,878 | Direct |
| Oct 28, 2024 | RLAY Relay Therapeutics, Inc. | Sale(S) | 2,688 | $6.06 | $16,289 | Direct |
| Sep 27, 2024 | RLAY Relay Therapeutics, Inc. | Sale(S) | 648 | $7.51 | $4,866 | Direct |
1-24 of 24 transactions
About Bergstrom Donald A
Bergstrom Donald A (SEC CIK 0001709772) files insider reports with the SEC as President, R&D of Relay Therapeutics, Inc. (RLAY).
Signal8 holds 17 ownership filings by Bergstrom Donald A, all Form 4s, filed between Oct 1, 2024 and Oct 30, 2026. Those filings report 24 transactions, from Sep 27, 2024 to Oct 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bergstrom Donald A's filings is in CAMBRIDGE, MA.
Recent filings by Bergstrom Donald A
- Oct 28, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Sep 8, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Jul 28, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Jul 6, 2026: Open-market sale of RLAY shares (Form 4, code S).
- Jun 22, 2026: Open-market sale of RLAY shares (Form 4, code S).
Other insiders filing for Relay Therapeutics, Inc. (RLAY)
- Rahmer Peter
- Catinazzo Thomas, Chief Financial Officer
- Patel Sanjiv, President and CEO
- SVF Pauling (Cayman) Ltd, 10% Owner
- Mazumdar Claire, Director
- Dable Habib J, Director